Ostatní
Návod 
Sutro Biopharma, Inc.
STRO
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.1B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
248%
ROA
-103%
PE
-1
PS
2
Cena 1R
5-22
⌀ Cena
8.92
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
12-03-2026
Poslední dividenda
Profil
Společnost Sutro Biopharma, Inc. působí jako klinická společnost zabývající se objevováním, vývojem a výrobou léčiv. Zaměřuje se na tvorbu proteinové terapie pro rakovinu a autoimunitní poruchy prostřednictvím integrované syntézy nebuněčných proteinů a lokálně specifické konjugační platformy, XpressCF+.Produktovými kandidáty společnosti jsou STRO-001, protilátkově-lékový konjugát (ADC) zaměřený proti rakovinnému cíli CD74 pro pacienty s mnohočetným myelomem a non-Hodgkinským lymfomem, který je ve fázi 1 klinických studií; a STRO-002, ADC zaměřený proti folátovému receptoru alfa pro pacienty s rakovými a endometriálními nádory, který je ve fázi Klinické studie fáze 1. Má spolupráci a licenční smlouvy s Merck Collaboration na vývoji výzkumných programů zaměřených na deriváty cytokinů pro rakovinu a autoimunitní poruchy; a Celgene Corporation na objevení a vývoj bispecifických protilátek a/nebo ADC zaměřených na oblast imuno-onkologie. Společnost byla dříve známá jako Basic Applied Biology, Inc. Sutro Biopharma, Inc. byla založena v roce 2003 a sídlí v Jižním San Francisku v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
269
Založení
2018-09-27
Podobné společnosti
$ 4.30
- $ 0.02
$ 1.64
+ $ 0.04
$ 1.55
+ $ 0.32
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 102.5 | 102.5 | 62.0 | 153.7 | 67.8 | 61.9 | 42.7 | 42.7 | 38.4 | 51.7 | 59.7 | |
| Cost of Revenues | 1.6 | 7.3 | 7.2 | 6.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 100.9 | 95.2 | 54.8 | 146.9 | 67.8 | 61.9 | 42.7 | 42.7 | 38.4 | 51.7 | 59.7 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 11.6 | 9.7 | 63.7 | 17.4 | 14.8 | 8.5 | 25.7 | 13.0 | 113.7 | 16.9 | |
| Cost of Revenues | 1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 1.8 | 1.7 | 1.7 | |
| Gross Profit | 10.0 | 9.7 | 63.7 | 17.4 | 14.8 | 8.5 | 23.9 | 11.2 | 112.0 | 15.2 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 180.4 | 137.2 | 104.4 | 77.0 | 65.6 | 54.3 | 54.6 | 43.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 62.6 | 59.5 | 56.0 | 36.8 | 32.6 | 21.4 | 16.4 | 14.8 | |
| Depreciation & Amortization | 7.3 | 7.3 | 7.2 | 6.8 | 3.5 | 5.4 | 5.8 | 8.9 | 4.5 | 5.0 | 5.7 | |
| Total Operating Expenses | 254.8 | 200.1 | 293.3 | 243.0 | 196.7 | 160.4 | 113.8 | 98.2 | 75.6 | 71.0 | 58.4 | |
| Operating Income | -154.0 | -105.0 | -238.5 | -89.3 | -128.9 | -98.5 | -71.1 | -55.5 | -37.2 | -19.3 | 1.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 53.8 | 45.7 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.1 | 15.3 | ||
| Depreciation & Amortization | 1.6 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | ||
| Total Operating Expenses | 43.7 | 58.2 | 67.1 | 85.9 | 80.1 | 76.4 | 72.6 | 67.8 | 68.8 | 60.9 | ||
| Operating Income | -33.7 | -48.5 | -3.3 | -68.5 | -65.3 | -67.9 | -48.7 | -56.6 | 43.2 | -44.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 9.3 | 9.3 | 44.4 | 14.5 | 3.5 | 0.6 | 1.5 | 4.1 | 1.6 | 0.3 | 0.3 | |
| Interest Expense | 40.2 | 38.2 | 31.1 | 23.8 | 3.3 | 3.1 | 4.1 | 4.4 | 1.6 | 0.6 | 0.0 | |
| Other Expense | -37.2 | -86.2 | 13.4 | 0.7 | 12.2 | -7.0 | 38.9 | -0.3 | 1.9 | -0.1 | 0.1 | |
| IBT | -191.2 | -191.2 | -225.1 | -88.6 | -116.7 | -105.5 | -32.1 | -55.7 | -35.3 | -19.7 | 1.7 | |
| Income Tax Expense | -0.1 | -0.1 | 2.4 | 18.2 | 2.5 | 3.1 | 4.1 | 0.0 | 3.5 | 0.5 | 0.1 | |
| Net Income | -191.1 | -191.1 | -227.5 | -106.8 | -119.2 | -108.7 | -36.2 | -55.7 | -35.3 | -19.7 | 1.7 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.5 | 2.0 | 2.5 | 3.2 | 3.9 | 27.0 | 4.9 | 4.1 | 4.6 | 4.6 | ||
| Interest Expense | 9.5 | 10.4 | 9.6 | 10.6 | 8.7 | 7.9 | 9.0 | 9.4 | 8.7 | 8.7 | ||
| Other Expense | -13.2 | -8.4 | -8.2 | -7.5 | -4.8 | 19.1 | 0.7 | -1.6 | 3.7 | -3.4 | ||
| IBT | -46.8 | -56.9 | -11.5 | -76.0 | -70.1 | -48.8 | -48.0 | -58.2 | 46.9 | -47.4 | ||
| Income Tax Expense | -0.1 | 0.0 | 0.0 | 0.0 | 2.4 | 0.0 | 0.0 | 0.0 | 15.8 | 1.8 | ||
| Net Income | -46.8 | -56.9 | -11.5 | -76.0 | -72.4 | -48.8 | -48.0 | -58.2 | 31.1 | -49.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-17.80 | $-23.50 | $-22.90 | $-9.90 | $-24.30 | $-15.50 | $-28.10 | $38.60 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-17.80 | $-23.50 | $-22.90 | $-9.90 | $-24.30 | $-15.40 | $-28.10 | $38.60 | |
| Shares Outstanding | 8.6 | 8.5 | 7.7 | 6.0 | 5.1 | 4.6 | 3.3 | 2.3 | 2.3 | 0.7 | 0.0 | |
| Diluted Shares Outstanding | 8.6 | 8.5 | 7.7 | 6.0 | 5.1 | 4.6 | 3.3 | 2.3 | 2.3 | 0.7 | 0.0 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.10 | $-8.10 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.10 | $-8.10 | ||
| Shares Outstanding | 8.6 | 8.5 | 8.5 | 8.3 | 8.3 | 8.2 | 8.1 | 6.1 | 6.1 | 6.1 | ||
| Diluted Shares Outstanding | 8.6 | 8.5 | 8.5 | 8.3 | 8.3 | 8.2 | 8.1 | 6.1 | 6.1 | 6.1 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 90.8 | 190.3 | 69.3 | 47.3 | 30.4 | 206.2 | 5.0 | 125.3 | 22.0 | 11.6 | |
| Short Term Investments | 335.2 | 126.6 | 306.4 | 287.1 | 167.5 | 162.0 | 112.9 | 79.2 | 0.0 | 35.9 | |
| Total Cash & ST Investments | 426.0 | 316.9 | 375.6 | 302.3 | 197.9 | 368.1 | 117.9 | 204.5 | 22.0 | 47.5 | |
| Accounts Receivable | 7.0 | 8.6 | 36.1 | 7.1 | 12.5 | 5.6 | 6.3 | 2.5 | 1.6 | 0.6 | |
| Inventory | 0.0 | 0.0 | 0.0 | -11.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 10.5 | 17.8 | 9.8 | 11.7 | 8.1 | 4.5 | 4.4 | 3.0 | 2.0 | 1.6 | |
| Total Current Assets | 443.5 | 343.3 | 421.5 | 309.5 | 218.5 | 378.2 | 128.6 | 209.9 | 25.6 | 49.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 65.9 | 64.0 | 106.2 | 190.3 | 174.6 | 90.8 | 65.2 | 69.3 | 81.8 | 235.1 | |
| Short Term Investments | 101.7 | 141.1 | 142.7 | 126.6 | 213.7 | 335.2 | 248.0 | 306.4 | 273.3 | 156.5 | |
| Total Cash & ST Investments | 167.6 | 205.1 | 249.0 | 316.9 | 388.3 | 426.0 | 313.2 | 375.6 | 355.2 | 391.6 | |
| Accounts Receivable | 3.9 | 8.0 | 13.6 | 8.6 | 6.7 | 7.0 | 31.3 | 36.1 | 16.6 | 10.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 10.6 | 18.5 | 24.9 | 17.8 | 10.9 | 10.5 | 10.1 | 9.8 | 9.5 | 10.3 | |
| Total Current Assets | 182.1 | 231.6 | 287.4 | 343.3 | 405.8 | 443.5 | 354.6 | 421.5 | 381.3 | 412.0 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 39.7 | 35.9 | 44.8 | 51.1 | 51.6 | 12.9 | 9.6 | 10.9 | 14.0 | 18.7 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.9 | 0.0 | 0.0 | 32.0 | 68.8 | 0.0 | 15.6 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 5.0 | 8.0 | 4.4 | 14.4 | 2.5 | 3.0 | 2.6 | 2.3 | 1.1 | 0.9 | |
| Total Long-Term Assets | 45.6 | 43.9 | 49.2 | 97.5 | 122.9 | 15.9 | 27.8 | 13.2 | 15.1 | 19.6 | |
| Total Assets | 489.0 | 387.2 | 470.7 | 406.9 | 341.4 | 394.1 | 156.4 | 223.1 | 40.8 | 69.3 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 26.7 | 29.8 | 33.1 | 35.9 | 38.0 | 39.7 | 42.2 | 44.8 | 46.3 | 48.8 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -34.0 | -33.3 | |
| Other Long-Term Assets | 0.9 | 0.1 | 0.9 | 8.0 | 8.0 | 5.8 | 6.6 | 4.4 | 38.2 | 37.5 | |
| Total Long-Term Assets | 27.5 | 30.7 | 34.0 | 43.9 | 46.1 | 45.6 | 48.8 | 49.2 | 50.5 | 52.9 | |
| Total Assets | 209.7 | 262.4 | 321.4 | 387.2 | 451.8 | 489.0 | 403.4 | 470.7 | 431.7 | 464.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.1 | 10.5 | 9.4 | 32.8 | 11.3 | 5.5 | 5.6 | 3.1 | 2.9 | 3.4 | |
| Short-Term Debt | 6.9 | 7.5 | 16.9 | 17.1 | 10.4 | 8.8 | 1.0 | 4.7 | 14.6 | 3.2 | |
| Other Current Liabilities | 43.0 | 44.1 | 31.6 | -17.1 | 14.5 | 0.6 | 6.9 | 7.1 | 3.7 | 0.0 | |
| Current Liabilities | 130.0 | 131.9 | 93.7 | 139.5 | 41.7 | 29.6 | 33.0 | 36.4 | 32.0 | 50.2 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.0 | 4.3 | 8.2 | 10.5 | 6.2 | 6.1 | 7.5 | 9.4 | 5.5 | 3.9 | |
| Short-Term Debt | 8.0 | 8.1 | 7.8 | 7.5 | 7.2 | 6.9 | 6.7 | 16.9 | 19.5 | 22.1 | |
| Other Current Liabilities | 47.9 | 49.9 | 48.1 | 44.1 | 45.3 | 43.0 | 29.7 | 31.6 | 24.6 | 23.2 | |
| Current Liabilities | 71.9 | 74.2 | 133.0 | 131.9 | 131.3 | 130.0 | 79.5 | 93.7 | 73.6 | 67.1 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 163.9 | 196.5 | 23.2 | 50.4 | 47.0 | 24.5 | 8.9 | 10.0 | 0.0 | 0.0 | |
| Capital Leases | 19.6 | 23.2 | 29.6 | 34.2 | 32.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 19.6 | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 0.4 | 0.5 | 0.0 | 0.0 | |
| Total Liabilities | 336.9 | 342.6 | 321.1 | 189.9 | 88.8 | 62.1 | 58.6 | 91.6 | 149.8 | 160.2 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 9.7 | 211.6 | 13.6 | 196.5 | 189.6 | 19.6 | 21.4 | 23.2 | 24.9 | 26.5 | |
| Capital Leases | 17.7 | 19.6 | 21.4 | 23.2 | 24.9 | 26.5 | 28.1 | 23.2 | 31.0 | 32.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 23.2 | -142.8 | -136.7 | |
| Total Liabilities | 296.9 | 294.5 | 347.2 | 342.6 | 340.6 | 336.9 | 305.4 | 321.1 | 319.4 | 310.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -665.6 | -786.9 | -559.4 | -452.6 | -333.4 | -227.9 | -195.7 | -150.3 | -115.0 | -95.3 | |
| Comprehensive Income | -0.2 | 0.0 | 0.0 | -0.6 | -0.3 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 152.2 | 44.6 | 149.6 | 217.0 | 252.6 | 332.0 | 97.8 | 131.5 | -109.0 | -90.9 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -931.2 | -874.3 | -862.8 | -786.9 | -714.4 | -665.6 | -617.6 | -559.4 | -590.5 | -541.2 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | -0.2 | -0.1 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | -87.3 | -32.1 | -25.8 | 44.6 | 111.2 | 152.2 | 98.0 | 149.6 | 112.3 | 154.7 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 190.4 | 204.0 | 33.6 | 67.5 | 57.4 | 24.5 | 9.9 | 14.7 | 14.6 | 0.0 | |
| Book Value | 152.2 | 44.6 | 149.6 | 217.0 | 252.6 | 332.0 | 97.8 | 131.5 | -109.0 | -90.9 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -87.3 | -32.1 | -25.8 | 44.6 | 111.2 | 152.2 | 98.0 | 149.6 | 112.3 | 154.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -124.5 | -191.1 | -227.5 | -106.8 | -119.2 | -105.5 | -32.1 | -55.7 | -35.3 | -19.7 | 1.7 | |
| Depreciation & Amortization | 7.0 | 7.3 | 7.2 | 6.8 | 5.7 | 4.8 | 4.3 | 4.8 | 4.5 | 5.0 | 5.7 | |
| Stock-Based Compensation | 24.5 | 14.0 | 24.7 | 24.9 | 26.3 | 23.2 | 11.9 | 10.3 | 2.9 | 1.4 | 1.0 | |
| Change Working Capital | 13.9 | -50.4 | 8.9 | -34.4 | 104.4 | -17.6 | -11.5 | -23.3 | 42.6 | -26.9 | -21.7 | |
| Change In Accounts Receivable | 3.0 | 4.6 | 27.5 | -29.0 | 5.3 | -6.9 | 0.7 | -3.8 | -0.9 | -1.0 | -0.2 | |
| Change In Accounts Payable | 2.2 | -2.5 | 0.7 | 4.8 | -1.2 | 6.4 | -0.9 | 2.3 | 0.2 | -0.5 | 0.9 | |
| Change In Inventories | -10.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.5 | -0.1 | -1.3 | -1.7 | -0.4 | -0.4 | |
| Other Non-cash Items | 26.0 | 42.9 | -4.9 | -2.2 | -13.6 | 6.2 | 0.6 | 0.2 | -0.5 | 0.1 | 0.1 | |
| Cash from Operations | -74.7 | 0.0 | 0.0 | -111.6 | 3.5 | -81.7 | -67.8 | -65.0 | 12.7 | -37.1 | -13.2 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -46.8 | -56.9 | -11.5 | -76.0 | -72.4 | -48.8 | -48.0 | -58.2 | 31.1 | -49.3 | |
| Depreciation & Amortization | 1.6 | 1.9 | 1.9 | 1.9 | 1.9 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | |
| Stock-Based Compensation | 1.7 | 1.6 | 5.3 | 5.5 | 5.9 | 6.5 | 6.2 | 0.0 | 6.2 | 6.0 | |
| Change Working Capital | 4.7 | 4.6 | -50.6 | -9.1 | -15.7 | -7.1 | 48.4 | -16.6 | -21.6 | 3.7 | |
| Change In Accounts Receivable | -0.1 | 4.1 | 5.6 | -4.9 | -2.0 | 0.3 | 24.4 | 4.8 | -19.5 | -6.6 | |
| Change In Accounts Payable | 0.6 | 2.7 | -3.8 | -1.9 | 4.1 | -0.1 | -1.4 | -1.9 | 4.1 | 1.4 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -12.9 | 2.9 | |
| Other Non-cash Items | 12.4 | 10.6 | 10.2 | 9.8 | 8.7 | -17.0 | 1.2 | 8.3 | 21.7 | 7.4 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.1 | -33.5 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -3.0 | -1.7 | -3.1 | -4.3 | -7.9 | -15.3 | -7.1 | -3.5 | -1.6 | -3.3 | -4.4 | |
| Acquisitions | 135.8 | 0.0 | 0.0 | 0.0 | 28.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -611.3 | -265.0 | -461.5 | -460.3 | -216.7 | -248.7 | -130.7 | -196.2 | -81.5 | -14.2 | -52.3 | |
| Sales of Investment | 460.4 | 311.7 | 683.1 | 460.7 | 189.5 | 166.7 | 138.4 | 148.6 | 2.8 | 50.1 | 66.3 | |
| Other Investing Activities | -71.2 | 0.0 | 0.0 | 0.0 | -28.7 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | |
| Cash from Investing | -153.8 | 0.0 | 0.0 | -3.9 | -35.0 | -97.3 | 0.6 | -51.1 | -80.2 | 32.6 | 9.6 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.2 | -0.3 | -0.1 | -1.2 | -1.1 | -0.8 | -0.8 | -0.4 | -1.4 | -0.3 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 22.1 | 113.7 | |
| Investments | -4.0 | -89.9 | -28.6 | -142.4 | -126.0 | -43.2 | -157.3 | -135.0 | -80.6 | -238.4 | |
| Sales of Investment | 22.9 | 130.2 | 31.3 | 127.3 | 214.6 | 191.3 | 77.7 | 199.6 | 58.5 | 124.7 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -22.1 | -113.7 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -23.5 | -114.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -10.3 | 0.0 | 0.0 | -12.5 | -9.4 | 0.0 | -10.0 | -5.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 158.1 | 204.0 | 170.3 | -21.4 | 19.5 | 32.8 | 24.7 | 0.2 | 0.1 | 14.6 | 0.0 | |
| Issuance of Common Stock | 97.6 | 0.0 | 0.0 | 12.0 | 56.3 | 0.0 | 251.4 | 0.2 | 84.4 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -139.2 | 0.0 | 0.0 | 138.1 | 1.4 | 3.3 | 27.8 | 0.6 | 86.3 | 14.6 | 0.2 | |
| Cash from Financing | 84.2 | 0.0 | 0.0 | 137.6 | 48.3 | 3.3 | 269.2 | -4.2 | 170.8 | 14.6 | 0.2 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.1 | -3.1 | |
| Debt Issued | 17.7 | -202.0 | 198.3 | -182.6 | 7.1 | 170.3 | -1.5 | -154.7 | 147.7 | -1.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | 1.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.6 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.1 | -5.7 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -144.3 | -132.2 | 121.0 | 22.0 | 16.8 | -175.7 | 202.0 | -120.3 | 103.3 | 10.2 | -3.4 | |
| Closing Cash Balance | 90.8 | 59.0 | 191.2 | 70.1 | 48.1 | 31.3 | 207.0 | 5.0 | 125.3 | 22.0 | 11.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -7.8 | 1.9 | -42.2 | -84.1 | 15.7 | 83.8 | 25.6 | -4.1 | -12.6 | -153.3 | |
| Closing Cash Balance | 59.0 | 65.9 | 64.9 | 107.1 | 191.2 | 175.4 | 91.6 | 65.2 | 69.3 | 82.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -77.7 | -178.9 | -194.6 | -115.9 | -4.3 | -97.0 | -74.9 | -68.5 | 11.1 | -40.4 | -17.5 | |
| Real Free Cash Flow | -102.1 | -192.9 | -219.3 | -140.8 | -30.6 | -120.2 | -86.8 | -78.8 | 8.3 | -41.8 | -18.5 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -26.6 | -38.4 | -44.8 | -69.1 | -72.8 | -65.3 | 8.7 | -65.2 | 12.6 | -33.8 | |
| Real Free Cash Flow | -28.3 | -40.0 | -50.1 | -74.6 | -78.7 | -71.9 | 2.5 | -65.2 | 6.4 | -39.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -0.9 | -2.9 | -1.4 |
| P/S | 1.7 | 5.9 | 9.4 |
| P/B | -2 | 1.4 | 5.2 |
| P/FCF | -0.9 | 1.6 | -1.5 |
| Market cap | $0.1 | $0.9 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 8.4 % | 12.7 % | 0 % |
| Debt to Income | -9.2 % | -38.3 % | 0 % |
| Debt to Free cash flow | -9.2 % | -325.1 % | 0 % |
| Interest expense percentage | -26.1 % | -9.9 % | 44.7 % |
| Current ratio | 2.5 | 5 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 219 % | 18.9 % | 0 % |
| ROA | -91.1 % | -32.3 % | 0 % |
| CapEx to Revenue | 2.4 % | 10 % | 0 % |
| RaD to Revenue | 0 % | 146.4 % | 0 % |
| ROEM | 330,593.5 | 231683.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 100 % | 98.6 % | 68.7 % |
| Operating margin | -175.7 % | -150.8 % | 35.5 % |
| Net margin | -205.2 % | -140.8 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 8.5 mil | 4.4 mil |
| Employee count | 0.3 tis | 0.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
